Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey

↑ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 87 days • 1 price levels

Days at Price

Price Analysis

Most common price: £325 (87 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 87 days

Description

This econometric study covers the outlook for anti-migraine drugs in Europe & the Middle East. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries in Europe & the Middle East). This study gives, however, my estimates for the latent demand, or the P.I.E. for anti-migraine drugs in Europe & the Middle East. It also shows how the P.I.E. is divided across the national markets of Europe & the Middle East. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Product Specifications

Format: paperback
ASIN: B00E4DC8UO
Category: Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain: Amazon UK
Release Date: 17 July 2013
Listed Since: 24 July 2013

It has never been this cheap. We have no record of a lower price.

The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2013-2018 Outlook for Anti-Migraine Drugs in Africa

The 2023-2028 Outlook for Anti-Migraine Drugs in China

Anti-Migraine Drugs in Europe Outlook 2016-2021 Report

Anti-Migraine Drug Outlook: Africa & Middle East Study

Anti-Migraine Drug Outlook in Asia 2016-2021 Study

Anti-Migraine Drug Outlook in Middle East (2011-2016)

The 2023-2028 Outlook for Anti-Migraine Drugs in Japan

Anti-Migraine Drug Outlook North America & Caribbean Study

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

US Anti-Migraine Drug Market Outlook 2023-2028 Study

Anti-Migraine Drug Outlook in Oceana 2016-2021 Study

Anti-Migraine Drugs in India Outlook 2023-2028 Study

US Anti-Migraine Drug Market Outlook 2016-2021 Study

The 2021-2026 World Outlook for Anti-Migraine Drugs

The 2016-2021 Outlook for Anti-Migraine Drugs in India

Anti-Migraine Drug Outlook in Greater China 2016-2021

US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

2025-2030 World Outlook for Anti-Migraine Drugs Study

The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

Migraine and Headache Disorders: Global Perspective - SDG3

Management of Migraine Pain: Emerging Opportunities and Challenges

Interventional Management of Migraines and Headache Disorders Book

It has never been this cheap. We have no record of a lower price.

The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2013-2018 Outlook for Anti-Migraine Drugs in Africa

The 2023-2028 Outlook for Anti-Migraine Drugs in China

Anti-Migraine Drugs in Europe Outlook 2016-2021 Report

Anti-Migraine Drug Outlook: Africa & Middle East Study

Anti-Migraine Drug Outlook in Asia 2016-2021 Study

Anti-Migraine Drug Outlook in Middle East (2011-2016)

The 2023-2028 Outlook for Anti-Migraine Drugs in Japan

Anti-Migraine Drug Outlook North America & Caribbean Study

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

US Anti-Migraine Drug Market Outlook 2023-2028 Study

Anti-Migraine Drug Outlook in Oceana 2016-2021 Study

Anti-Migraine Drugs in India Outlook 2023-2028 Study

US Anti-Migraine Drug Market Outlook 2016-2021 Study

The 2021-2026 World Outlook for Anti-Migraine Drugs

The 2016-2021 Outlook for Anti-Migraine Drugs in India

Anti-Migraine Drug Outlook in Greater China 2016-2021

US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

2025-2030 World Outlook for Anti-Migraine Drugs Study

The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

Migraine and Headache Disorders: Global Perspective - SDG3

Management of Migraine Pain: Emerging Opportunities and Challenges

Interventional Management of Migraines and Headache Disorders Book